NDC 0085-1177

Integrilin

Eptifibatide

Integrilin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Eptifibatide.

Product ID0085-1177_0b07e9e2-08a4-4b8f-a3d5-81dfe25f2031
NDC0085-1177
Product TypeHuman Prescription Drug
Proprietary NameIntegrilin
Generic NameEptifibatide
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-01-23
Marketing CategoryNDA / NDA
Application NumberNDA020718
Labeler NameMerck Sharp & Dohme Corp.
Substance NameEPTIFIBATIDE
Active Ingredient Strength2 mg/mL
Pharm ClassesDecreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0085-1177-01

1 VIAL, SINGLE-USE in 1 CARTON (0085-1177-01) > 10 mL in 1 VIAL, SINGLE-USE
Marketing Start Date1998-05-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0085-1177-03 [00085117703]

Integrilin INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-01-23

NDC 0085-1177-05 [00085117705]

Integrilin INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-01-23

NDC 0085-1177-02 [00085117702]

Integrilin INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-05-18

NDC 0085-1177-01 [00085117701]

Integrilin INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-05-18

Drug Details

Active Ingredients

IngredientStrength
EPTIFIBATIDE2 mg/mL

OpenFDA Data

SPL SET ID:5423624f-a2d8-4273-8c62-51839fccfd7e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 261097
  • 1736478
  • 1736477
  • 1736472
  • 1736470
  • 200349
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • Platelet Aggregation Inhibitor [EPC]

    NDC Crossover Matching brand name "Integrilin" or generic name "Eptifibatide"

    NDCBrand NameGeneric Name
    0085-1136IntegrilinEptifibatide
    0085-1177IntegrilinEptifibatide
    0338-9558EptifibatideEptifibatide
    0338-9559EptifibatideEptifibatide
    0703-1165EptifibatideEptifibatide
    14335-070Eptifibatideeptifibatide
    14335-071Eptifibatideeptifibatide
    16729-259EPTIFIBATIDEEptifibatide
    16729-260EPTIFIBATIDEEptifibatide
    17478-902EptifibatideEptifibatide
    17478-903EptifibatideEptifibatide
    25021-408eptifibatideeptifibatide
    25021-409eptifibatideeptifibatide
    52958-040EptifibatideEptifibatide
    52958-402EptifibatideEptifibatide

    Trademark Results [Integrilin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    INTEGRILIN
    INTEGRILIN
    75009658 2234543 Live/Registered
    MILLENNIUM PHARMACEUTICALS, INC.
    1995-10-11

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.